Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of Yisuishengxue Granule in non-transfusion-dependent alpha-thalassemia
CTR20201285Phase 2Active
- Sponsor
- 北京一诺信远医药科技有限公司/ 中国中医科学院广安门医院
- Start
- Sep 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yisuishengxue Granule in alpha thalassemia, Thalassaemia, sponsored by 北京一诺信远医药科技有限公司/ 中国中医科学院广安门医院. Started Sep 2020; status: active.
02
Drugs
Yisuishengxue Granule
03
Conditions
alpha thalassemiaThalassaemia
Beyond the preview
Go deeper on CTR20201285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201285.